56 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35355718 | HIF1α/VEGF Feedback Loop Contributes to 5-Fluorouracil Resistance. | 2022 | 4 |
2 | 32190532 | Poly(1-vinylimidazole) polyplexes as novel therapeutic gene carriers for lung cancer therapy. | 2020 | 1 |
3 | 30952738 | Cytoplasmic E-Cadherin Expression Is Associated With Higher Tumour Level of VEGFA, Lower Response Rate to Irinotecan-based Treatment and Poorer Prognosis in Patients With Metastatic Colorectal Cancer. | 2019 Apr | 1 |
4 | 31127996 | Efficacy and adverse reactions of combination therapy of bevacizumab and 5-fluorouracil in patients with metastatic colon cancer. | 2019 Mar-Apr | 1 |
5 | 30111992 | Corneal Epithelial Hyperplasia after 5-Fluorouracil Injection. | 2018 Jan-Apr | 2 |
6 | 30151975 | Bevacizumab-enhanced antitumor effect of 5-fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2-specificity protein 1 pathway. | 2018 Oct | 1 |
7 | 30271631 | Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery. | 2018 | 2 |
8 | 28454454 | Chemotherapy regimen based on sorafenib combined with 5-FU on HIF-1α and VEGF expression and survival in advanced gastric cancer patients. | 2017 Apr | 1 |
9 | 29137307 | Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A/VEGF signaling pathway and down-regulation of MDR-1 and P-gp expression in gastric cancer. | 2017 Oct 10 | 1 |
10 | 24171833 | Expression of vascular endothelial growth factor (VEGF) in macrophages, fibroblasts, and endothelial cells in pterygium treated with 5-Fluorouracil. | 2015 May | 4 |
11 | 25707392 | Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy. | 2015 Oct | 2 |
12 | 25995742 | Polyunsaturated fatty acids augment tumoricidal action of 5-fluorouracil on gastric cancer cells by their action on vascular endothelial growth factor, tumor necrosis factor-α and lipid metabolism related factors. | 2015 Apr 25 | 2 |
13 | 27551256 | Update on Anti-Angiogenesis Therapy in Colorectal Cancer. | 2015 Dec | 1 |
14 | 25419401 | Effect of angiogenesis inhibitor SU6668 in combination with 5-Fu on liver metastasis from transplantation tumors of human colorectal cancer in nude mice. | 2014 | 4 |
15 | 23374220 | The relationship of vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer. | 2013 Feb 1 | 2 |
16 | 23508585 | PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma. | 2013 Dec | 1 |
17 | 23645743 | Chemotherapeutic alteration of VEGF, PDGF and PDGFRα/β expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro. | 2013 May | 2 |
18 | 23810214 | A study of the combination of triamcinolone and 5-fluorouracil in modulating keloid fibroblasts in vitro. | 2013 Sep | 1 |
19 | 23997941 | Continuum of care with anti-angiogenic therapies in metastatic colorectal cancer. | 2013 Sep | 2 |
20 | 22767582 | VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA. | 2012 Nov | 1 |
21 | 23155356 | VEGF -634C/G genotype is predictive of long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. | 2012 | 2 |
22 | 23295255 | Prognostic significance of serum levels of vascular endothelial growth factor and insulin-like growth factor-1 in advanced gastric cancer patients treated with FOLFOX chemotherapy. | 2012 | 1 |
23 | 23481572 | Low dose chemotherapeutic drugs without overt cytotoxic effects decrease the secretion of VEGF by cultured human tumor cells: a tentative relationship between drug type and tumor cell type response. | 2012-2013 | 1 |
24 | 20811948 | Tyrosine kinase inhibitor PTK/ZK enhances the antitumor effects of interferon-α/5-fluorouracil therapy for hepatocellular carcinoma cells. | 2011 Feb | 2 |
25 | 21057529 | Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells. | 2011 Mar 10 | 1 |
26 | 21188390 | Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab. | 2011 Feb | 1 |
27 | 21555362 | VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea. | 2011 Aug | 1 |
28 | 21809488 | Late anastomotic colonic dehiscence due to antiangiogenic treatment, a specific drug-class complication requiring specific treatment: an example of pazopanib complication. | 2011 Feb | 1 |
29 | 22066110 | Up-regulation of cyclooxygenase-2-derived prostaglandin E(2) in colon cancer cells resistant to 5-fluorouracil. | 2011 Aug | 1 |
30 | 20568543 | Effects of the combination of hyperbaric oxygen and 5-fluorouracil on proliferation and metastasis of human nasopharyngeal carcinoma CNE-2Z cells. | 2010 May-Jun | 1 |
31 | 19118048 | rNAPc2 inhibits colorectal cancer in mice through tissue factor. | 2009 Jan 1 | 1 |
32 | 19846936 | Glutathione modulation reverses the growth-promoting effect of growth factors, improving the 5-fluorouracil antitumour response in WiDr colon cancer cells. | 2009 Oct | 3 |
33 | 17851877 | Effect of interferon and 5-fluorouracil on serum VEGF levels in neuroendocrine tumours. | 2008 | 1 |
34 | 18494554 | A novel tumor-promoting function residing in the 5' non-coding region of vascular endothelial growth factor mRNA. | 2008 May 20 | 2 |
35 | 18501075 | Correlation between rash and a positive drug response associated with bevacizumab in a patient with advanced colorectal cancer. | 2008 Mar | 1 |
36 | 18566238 | Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis. | 2008 Jun | 2 |
37 | 18641541 | VEGF G-1154A is predictive of severe acute toxicities during chemoradiotherapy for esophageal squamous cell carcinoma in Japanese patients. | 2008 Aug | 3 |
38 | 18814928 | Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab. | 2008 Nov | 1 |
39 | 17522103 | Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatin. | 2007 Apr | 4 |
40 | 17673469 | Relationship between expression of vascular endothelial growth factor in tumor tissue from gastric cancers and chemotherapy effects: comparison between S-1 alone and the combination of S-1 plus CDDP. | 2007 Jul | 6 |
41 | 17715009 | [Biodistribution of (99m)Tc-labeled anti-VEGF mAb 5-FU loaded polylactic acid nanoparticles in human gastric carcinoma xenografts]. | 2007 Aug | 2 |
42 | 17786339 | Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins. | 2007 Oct | 1 |
43 | 17851795 | [Study of the anti-tumor effect of anti-vascular endothelial growth factor McAb 5-fluorouracil loaded polylactic acid nanoparticles]. | 2007 Sep | 10 |
44 | 16809149 | Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients. | 2006 Apr-May | 4 |
45 | 15709211 | Molecular imaging of antiangiogenic agents. | 2005 Feb | 1 |
46 | 16101140 | Circulating vascular endothelial growth factor and interferon-gamma-inducible protein-10 levels in pancreatic cancer during chemotherapy. | 2005 Sep-Oct | 2 |
47 | 16118771 | Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. | 2005 Sep 1 | 3 |
48 | 19956517 | Thymidylate synthase, thymidine phosphorylase, VEGF and p53 protein expression in primary colorectal cancer for predicting response to 5-fluorouracil-based chemotherapy. | 2005 Aug | 2 |
49 | 15031593 | The role of new agents in the treatment of colorectal cancer. | 2004 | 1 |
50 | 15280064 | Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation. | 2004 Jul-Aug | 2 |